Trifluoperazine Oral Solution
Trifluoperazine is an oral liquid medicine used to treat mental health difficulties and psychosis.
Low dosage Trifluoperazine is indicated as an adjunct in the short term management of:
Anxiety states
Depressive symptoms secondary to anxiety
Agitation
It is also indicated in the symptomatic treatment of nausea and vomiting.
High dosage Trifluoperazine is indicated for:
the treatment of symptoms and prevention of relapse in schizophrenia and in other psychoses, especially of the paranoid type, but not in depressive psychoses. It may also be used as an adjunct in the short term management of severe psychomotor agitation and of dangerously impulsive behaviour, for example, mental subnormality.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Trifluoperazine Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Trifluoperazine Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Trifluoperazine Oral Solution
| Click here for Audio Version | |
| Flavour | Aniseed and lime |
| Storage Conditions | Store below 25°C. Store in the original package in order to protect from light. |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 9 months / 1 month |
| PIP Code | 107-9409 |
| EAN Code | 50-16119-06489-0 |
| Sodium Levels | None |
| Ethanol Concentration | None |
Downloads
Adverse Drug Events
Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
